Introduction
interleukin-6 (IL-6) are strong predictors of adverse outcome in patients with an acute coronary syndrome [10-Patients with an acute coronary syndrome, either severe 12] . It has been demonstrated that an elevated CRP is not unstable angina (UA) or non-Q-wave myocardial infarction necessarily induced by ischemic injury, as normal CRP (NQMI), have a high risk of suffering a subsequent cardiac levels were measured after an episode of ischemia in events [1] [2] [3] . Several studies have shown that in about one patients with variant angina without atherosclerotic corthird of these patients, an elevated troponin T [4] [5] [6] [7] or onary artery disease [12] . Moreover, although myocardial troponin I (TnI) [8, 9] , can be found, and these elevations necrosis can cause an acute phase reaction by itself, Liuzzo are an indicator of a poor prognosis. Other studies have et al. reported an elevation of CRP in UA patients without shown that an increase in circulating concentrations of an abnormal troponin T [10] . Finally, myocardial necrosis acute phase reactants such as C-reactive protein (CRP) and was an unlikely cause of a modest elevation of CRP in a large group of patients with stable angina in the ECAT study, although no marker of necrosis was measured [13] . 0.2 mg / l, linearity was from 0.2-230 mg / l, and the Thus, both CRP and troponin T or I are prognostic coefficient of variation (C. V.) was ,3% at a concentration indicators in patients with unstable angina and NQMI, and of 2 mg / l. The 95th percentile in 120 healthy donors in our may have independent and additive prognostic value.
institution was established at 5.0 mg / l. The aim of this study was to asses the prognostic value TnI was measured with the fluorometric enzyme imof CRP and troponin I in patients with unstable angina or munoassay on the Stratus II (Dade, Miami, FL, USA). The NQMI for the occurrence of major cardiac events within 6 lower detection limit was 0.35 mg / l, linearity was from months.
0.35 to 50 mg / l, C. V. was 11.7% in the concentration range of 1.4 mg / l. The upper limit of normal as previously established [8] and according to the manufacturer was 0.4 2. Methods mg/l. CK-MB was measured with the Immuno-1 (Bayer, 2.1. Patients Leverkusen, Germany). The upper limit of normal was 7.0 mg / l, C. V. at 5.0 mg / l was 2.5%. Consecutive patients presenting at the cardiac emergency room of the Academic Medical Center with 2.3. Follow-up typical chest pain of ,8 h duration were eligible for the study. Patients were included if they had either diagnostic A 6-month follow-up was assessed by telephone inter-ST-segment depression or T-wave changes characteristic view, either with the patient, the cardiologist or general of myocardial ischemia. CK-MB was measured on admispractitioner caring for the patient, or the patient's relatives. sion, and at 5, 7 and 10 h after the onset of symptoms and, Primary outcome was defined as cardiac death, recurrent when CK-MB mass was abnormal, at frequent intervals non-fatal AMI or recurrent hospital admission for severe thereafter. The diagnosis for AMI was established accordunstable angina (defined as recurrent unstable angina at ing to the WHO criteria [14] , with a peak CK-MB above rest with diagnostic ST-segment depression or T-wave 14 mg / l (twice the upper limit of normal). Non-Q-wave changes characteristic of myocardial ischemia). Secondary AMI was considered present when peak CK-MB exceeded outcome was defined as (the need for) percutaneous 14 mg / l and no new Q-waves developed on the electrotransluminal coronary angioplasty or coronary bypass cardiogram. Patients with a peak CK-MB above the upper grafting. Patients underwent revascularization only when limit of normal (7.0 mg / l), but below the predefined limit they did not respond to optimal medical therapy. Physifor AMI were classified as unstable angina, as were cians caring for the patients during follow-up who were patients without CK-MB elevation.
responsible for scheduled revascularization procedures, Patients with ST-elevations on the admission-electrowere unaware of the CRP or TnI results. cardiogram that were candidates for reperfusion therapy (either primary PTCA or thrombolytic therapy) were excluded. Patients were also excluded when the evolution 2.4. Statistical analysis of the electrocardiogram showed the development of new left bundle branch block or new Q-waves. Other exclusion CRP and TnI were treated as a dichotomous variable criteria were a known or suspected infectious or inflamma-(either elevated or normal) with cut-off value for CRP: 5.0 tory condition and a scheduled revascularization procemg / l and for TnI: 0.4 mg / l. Two-by-two contingency dure. The protocol was approved by the institutions tables for the primary outcome were constructed for CRP. Medical Ethics Committee and all patients gave informed 5.0 mg / l, TnI.0.4 mg / l or both elevated. The prognostic consent. The investigation conforms with the principles value of CRP and TnI was assessed in a multivariate outlined in the Declaration of Helsinki. logistic regression model with the primary outcome as the dependent variable. Models with age, gender, history of 2.2. Assays hypertension, diabetes mellitus, previous myocardial infarction and 'aspirin use' in combination with either an CRP and TnI were measured from samples drawn on abnormal CRP, an abnormal TnI or both were compared admission, and results were kept blinded from the physiwith a log likelihood test. [16, 17] To assess event-free cians treating the patients. Blood samples were drawn in survival, Kaplan-Meier curves were constructed both for vacuum tubes containing lithium heparin, centrifuged, and the primary outcome and for all outcome including reremaining plasma stored at 2708C for later measurements.
vascularizations, and differences in mean survival were Patients were treated with aspirin, heparin i.v., nitrates i.v., compared using the log-rank test. Calculations were done b-blockers etc. according to a conservative management with a statistical software package (SPSS 6.01 for windows, strategy as outlined in the TIMI IIb trial [15] . SPSS, USA). All statistical comparisons were two-tailed, CRP was measured with a nephelometric assay (Behring and a P value of ,0.05 was considered statistically Diagnostics, Marburg, Germany). The detection limit was significant. performance in comparison with models with a single patients with unstable angina and 35 patients with non-Qmarker (P,0.001), demonstrating their independent prewave AMI. The patients' characteristics are summarized in dictive value. Table 1 , comparing patients that reached a primary end- Table 3 shows the event rate and mean event free point with the other patients. Follow-up at six month was survival for patients having both CRP and TnI elevated, 100% complete. There were 15 major cardiac events either CRP or TnI elevated or no CRP or TnI elevation. (10%) and 28 revascularizations (19%), listed in Table 2 Primary outcome was significantly more frequent in paOne patient died from lung cancer 30 days after admission tients having both CRP/ TnI elevated (10 / 24) than patient and this patient was censored at day 30. CRP values having either (5 / 58) or none elevated (0 / 68) (both vs. ranged from 0.0 to 76.1 mg / l (median 3.35; 25th and 75th either: P,0.0001; both vs. none: P,0.0001; either vs. percentiles 1.4 and 8.85 mg / l, respectively). An abnormal none: P50.015). Kaplan-Meier survival analysis showed CRP (.5.0 mg / l) was present in 61 patients (41%), that mean event-free survival for the primary outcome was significantly lower in patients having both CRP/ TnI elevated versus patients with either CRP/ TnI elevated or no Table 2 elevations ( Fig. 2a, P early in a substantial number of patients with unstable mean event free survival. The difference in the incidence angina and non-Q-wave AMI. It shows that CRP and TnI of events is apparent within the first two weeks, but the are independent prognostic indicators of adverse outcome.
survival curves continue to diverge during the subsequent The incidence of a major cardiac event was 23% in 6-month follow-up (Fig. 2) . In contrast, patients with both patients with an abnormal CRP vs. 1.1% in patients with a a normal CRP and TnI have an excellent prognosis. In this normal CRP. Moreover, in patients without a TnI elevapatient group there were no cardiac deaths, recurrent AMIs tion, a CRP.5.0 mg / l carried a significantly higher risk or recurrent admissions for unstable angina during the 6 for a major cardiac event within 6 months (11 vs. 0%).
months follow-up. Patients with both CRP and TnI elevated had the highest Our study confirms and extends the findings of one incidence of cardiac death, recurrent AMI or admission for recent report from the TIMI 11A substudy investigators, recurrent unstable angina within 6 months, and had a poor which demonstrated independent and combined prognostic Differences in proportions between groups were compared with the x statistic. Mean event-free survival was calculated with Kaplan-Meier survival analysis and differences were compared with the Log rank test. AMI5acute myocardial infarction; Rec. UAP5recurrent admission due to unstable angina pectoris; PTCA5percutaneous transluminal coronary angioplasty; CABG5coronary artery bypass grafting; CRP5C-reactive protein; TnI5troponin I. b Significant difference between group with either CRP or TnI vs. group with no elevations. c Significant difference between group with both CRP/ TnI vs. group with no elevations. d Significant difference between group with both CRP/ TnI vs. group with either CRP or TnI.
patients with an elevated troponin T in the FRISC study which used a cut-off value $1 mg / l. In contrast, Liuzzo et al. [10] demonstrated that CRP elevation in patients with unstable angina, without evidence of myocardial damage as assessed with troponin T, is associated with poor outcome. In addition, in another paper, Liuzzo et al.
showed that severe myocardial ischemia in patients with variant angina without atherosclerotic coronary artery disease does not by itself induce an increase in plasma CRP [12] . Therefore, it is likely that CRP elevations are due to activation of inflammation. It has been shown that other pro-inflammatory cytokines such as interleukin-6, interleukin-8 and TNF-a are elevated on admission in patients with acute coronary syndromes [11, 20, 21] , and that these elevations may be associated with a worse outcome [11] . We have previously shown that IL-6 has equivalent discriminatory capacity to the pro-coagulant factor fibrinopeptide A to distinquish between patients with stable and unstable coronary artery disease [22] . Whether CRP elevations are causal to the initiation of an episode of unstable coronary artery disease is unknown. It has been shown that CRP stimulates production of tissue factor by mononuclear cells, the main initiator of blood coagulation [23] . In addition, it has been suggested that CRP together with phospholipase A2 may cause complement activation and promote phagocytosis of damaged cells by activated neutrophils [24] . Unstable atherosclerotic [18], our findings suggest the possibility for risk stratification with the combination of these two markers. value of an abnormal CRP and a positive rapid troponin T
In conclusion, our study demonstrates the independent test for the prediction of 14-day mortality in patients with prognostic value of CRP and TnI in patients with unstable acute coronary syndromes [18] . Although the patient group angina or NQMI, for long term adverse outcome. Incidiffered due to different enrollment and timing of blood dence of events was high and mean event-free survival was samples, the troponin measured was I instead of T, and the low in patients with combined elevation of CRP and TnI, follow-up period was different, the results of our study are whereas prognosis is excellent for patients without elevaconsistent with the findings of the TIMI 11A substudy.
tions of CRP and TnI. These findings suggest that the In a substudy of the FRISC study, Toss et al. [19] could effects of a comprehensive treatment, e.g. with IIb / IIIa not demonstrate a worse outcome in patients with unstable antagonists, of patients with both markers elevated or early angina with increased CRP but no troponin T elevation. discharge of patients with both a normal CRP and TnI This may have been caused by the large proportion of could be studied in a prospective study.
